# OnCo record nobelpharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nobelpharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nobelpharma" ;
  schema:name "Nobelpharma"@en ;
  schema:alternateName "Nobelpharma Co., Ltd."@en, "ノーベルファーマ"@en ;
  schema:description "Nobelpharma is a Tokyo company founded in 2003 to develop medicines for rare diseases and unmet needs in Japan, including cancer treatments it takes through phase 3 trials."@en ;
  schema:url <https://onco.cc/companies/nobelpharma/>, <https://www.nobelpharma.co.jp> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.nobelpharma.co.jp>, <https://clinicaltrials.gov/search?lead=Nobelpharma>, <https://www.wikidata.org/wiki/Q11325922>, <https://www.nobelpharma.co.jp/en/research/product/> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "JP" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/> ;
  onco:drugs <https://onco.cc/drugs/dactinomycin/>, <https://onco.cc/drugs/streptozocin/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .